Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and cisplatin in esophageal cancer
NCT00072033Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Mar 2003
- Primary completion
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin in esophageal cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Mar 2003; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00072033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072033.